Department of Pathology, Albert Einstein College of Medicine, New York, New York, USA
Department of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California, Davis, Davis, California, USA.
mBio. 2021 May 18;12(3):e00603-21. doi: 10.1128/mBio.00603-21.
Our studies on novel cyst wall proteins serendipitously led us to the discovery that cyst wall and vacuolar matrix protein MAG1, first identified a quarter of a century ago, functions as a secreted immunomodulatory effector. MAG1 is a dense granular protein that is found in the parasitophorous vacuolar matrix in tachyzoite vacuoles and the cyst wall and matrix in bradyzoite vacuoles. In the current study, we demonstrated that MAG1 is secreted beyond the parasitophorous vacuole into the host cytosol in both tachyzoites and bradyzoites. Secretion of MAG1 gradually decreases as the parasitophorous vacuole matures, but prominent MAG1 puncta are present inside host cells even at 4 and 6 days following infection. During acute murine infection, Δ parasites displayed significantly reduced virulence and dissemination. In the chronic stage of infection, Δ parasites generated almost no brain cysts. To identify the mechanism behind the attenuated pathology seen with Δ parasites, various immune responses were screened using bone marrow-derived macrophages (BMDM). Infection of BMDM with Δ parasites induced a significant increase in interleukin 1β (IL-1β) secretion, which is a hallmark of inflammasome activation. Heterologous complementation of MAG1 in BMDM cells prevented this Δ parasite-induced IL-1β release, indicating that secreted MAG1 in host cytosol dampens inflammasome activation. Furthermore, knocking out GRA15 (an inducer of IL-1β release) in Δ parasites completely inhibited all IL-1β release by host cells following infection. These data suggest that MAG1 has a role as an immunomodulatory molecule and that by suppressing inflammasome activation, it would favor survival of the parasite and the establishment of latent infection. is an Apicomplexan that infects a third of humans, causing encephalitis in AIDS patients and intellectual disabilities in congenitally infected patients. We determined that one of the cyst matrix proteins, MAG1, which had been thought to be an innate structural protein, can be secreted into the host cell and suppress the host immune reaction. This particular immune reaction is initiated by another parasite-secreted protein, GRA15. The intricate balance of inflammasome activation by GRA15 and suppression by MAG1 protects mice from acute death while enabling parasites to disseminate and establish chronic cysts. Our finding contributes to our understanding of how parasites persist in the host and how modulates the host immune system.
我们对新型囊壁蛋白的研究意外地导致我们发现,囊壁和空泡基质蛋白 MAG1 作为一种分泌性免疫调节效应物发挥作用。MAG1 是一种致密颗粒蛋白,存在于速殖子空泡中的寄生空泡基质和缓殖子空泡中的囊壁和基质中。在本研究中,我们证明 MAG1 在速殖子和缓殖子中都能穿过寄生空泡分泌到宿主细胞质中。随着寄生空泡的成熟,MAG1 的分泌逐渐减少,但在感染后 4 天和 6 天,宿主细胞内仍存在明显的 MAG1 斑点。在急性鼠感染中,Δ 寄生虫的毒力和传播明显降低。在感染的慢性阶段,Δ 寄生虫几乎不会产生脑部囊肿。为了确定与 Δ 寄生虫相关的减弱病理学的机制,我们使用骨髓来源的巨噬细胞(BMDM)筛选了各种免疫反应。用 Δ 寄生虫感染 BMDM 会显著增加白细胞介素 1β(IL-1β)的分泌,这是炎症小体激活的标志。在 BMDM 细胞中异源互补 MAG1 可以防止这种 Δ 寄生虫诱导的 IL-1β释放,表明宿主细胞质中分泌的 MAG1 抑制了炎症小体的激活。此外,在 Δ 寄生虫中敲除 GRA15(IL-1β释放的诱导剂)完全抑制了感染后宿主细胞释放所有的 IL-1β。这些数据表明 MAG1 作为一种免疫调节分子发挥作用,并通过抑制炎症小体的激活,有利于寄生虫的存活和潜伏感染的建立。是一种感染了三分之一人类的顶复门寄生虫,会在艾滋病患者中引起脑炎,并在先天性感染患者中导致智力残疾。我们确定囊基质蛋白之一 MAG1 可以分泌到宿主细胞中,并抑制宿主的免疫反应,而 MAG1 曾被认为是一种先天结构蛋白。这种特殊的免疫反应是由另一种寄生虫分泌的蛋白 GRA15 引发的。GRA15 引发的炎症小体激活和 MAG1 抑制之间的微妙平衡,使小鼠免受急性死亡的影响,同时使寄生虫能够传播并建立慢性囊肿。我们的发现有助于我们理解寄生虫如何在宿主中持续存在以及如何调节宿主免疫系统。